A recent study published in the journal Gastroenterology has given the green light to fecal microbiota-based therapies for certain patients with recurrent Clostridioides difficile (C.difficile) infections. The study, conducted by
The American Gastroenterological Association (AGA) has issued the first evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, recommending fecal microbiota transplant (FMT) for most patients with
Hello everyone i'd like to thank you for attending today's docu-series letters of hope uh welcome to everyone in the room and welcome to everyone participating on our live stream
